These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6447998)

  • 1. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC; Jenkins R; Matsen JM
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    Pickering LK; Rutherford I
    J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin.
    Holt HA; Broughall JM; McCarthy M; Reeves DS
    Infection; 1976; 4(2):107-9. PubMed ID: 7534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
    Tindula RJ; Ambrose PJ; Harralson AF
    Drug Intell Clin Pharm; 1983 Dec; 17(12):906-8. PubMed ID: 6653408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions.
    Pieper JA; Vidal RA; Schentag JJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):604-9. PubMed ID: 6969576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
    Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
    J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
    Henderson JL; Polk RE; Kline BJ
    Am J Hosp Pharm; 1981 Aug; 38(8):1167-70. PubMed ID: 6455916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
    Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
    Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.
    Pickering LK; Gearhart P
    Antimicrob Agents Chemother; 1979 Apr; 15(4):592-6. PubMed ID: 464591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides.
    Riff LJ; Thomason JL
    J Antibiot (Tokyo); 1982 Jul; 35(7):850-7. PubMed ID: 7174538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.
    Thompson MI; Russo ME; Saxon BJ; Atkin-Thor E; Matsen JM
    Antimicrob Agents Chemother; 1982 Feb; 21(2):268-73. PubMed ID: 6462107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the interactions between piperacillin, ticarcillin, or carbenicillin and aminoglycoside antibiotics.
    Chanbusarakum P; Murray PR
    Antimicrob Agents Chemother; 1978 Sep; 14(3):505-6. PubMed ID: 101133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
    Falkowski AJ; Creger RJ
    Antimicrob Agents Chemother; 1984 Nov; 26(5):643-6. PubMed ID: 6393865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inactivation of gentamicin by carbenicillin and ticarcillin.
    Kradjan WA; Burger R
    Arch Intern Med; 1980 Dec; 140(12):1668-70. PubMed ID: 7458498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):474-7. PubMed ID: 6651276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
    Weibert R; Keane W; Shapiro F
    Trans Am Soc Artif Intern Organs; 1976; 22():439-43. PubMed ID: 951863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin-aminoglycoside inactivation: another possible mechanism of interaction.
    Russo ME
    Am J Hosp Pharm; 1980 May; 37(5):702-4. PubMed ID: 7386483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.